Immuneering (IMRX) EBIT Margin (2020 - 2022)
Immuneering's EBIT Margin came in at -3073627.91% for Q4 2022, down 3067764.89 percentage points from -5863.02% a year earlier and down 3039265.87 percentage points from the prior quarter.
Powered by 
Analysis
Immuneering (IMRX) EBIT Margin (2020 - 2022) Analysis & Trends
For FY2022, Immuneering's EBIT Margin was -16325.77%, down 14696.61 percentage points from FY2021.
- Going back by year, EBIT Margin was -1629.17% in FY2021 (-890.16 pp) and -739.01% in FY2020.
- The Q4 2022 figure represents the lowest quarterly EBIT Margin in data going back to Q2 2020.
- Year-over-year, EBIT Margin has declined for seven consecutive quarters, with an average year-over-year change of -446322.14 percentage points over the last seven quarters.
- Business Quant data shows IMRX's EBIT Margin at -34362.04% (Q3 2022), -12334.43% (Q2 2022) and -7036.37% (Q1 2022) in the three quarters before Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,147.31 Bn | 1,115.89 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 624.29 Bn | 542.81 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 511.65 Bn | 484.76 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 365.71 Bn | 320.09 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 297.61 Bn | 261.60 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 261.35 Bn | 235.03 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 234.89 Bn | 190.29 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.41 Bn | 168.60 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 172.08 Bn | 118.73 Bn | 10.94 Bn | 28.37% |
| 10 | Immuneering | 243.26 Mn | -463.73 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -3,073,627.91% |
| Sep 30, 2022 | -34,362.04% |
| Jun 30, 2022 | -12,334.43% |
| Mar 31, 2022 | -7,036.37% |
| Dec 31, 2021 | -5,863.02% |
| Sep 30, 2021 | -1,772.01% |
| Jun 30, 2021 | -1,210.67% |
| Mar 31, 2021 | -833.47% |
| Dec 31, 2020 | -877.56% |
| Sep 30, 2020 | -644.66% |
| Jun 30, 2020 | -750.08% |
API Access
Immuneering EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();